Becton, Dickinson and Company BDX

183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Becton, Dickinson and Company (BDX) P/S ratio

As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a P/S ratio of 2.3×. Over the past ten years it has ranged from 1.8× (June 2026) to 3.7× (September 2018); the current reading is higher than 18% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 1.9× (28.80%)
FY2024 2.7× (9.11%)
FY2023 3.0× 13.18%
FY2022 2.6× (7.20%)
FY2021 2.9× (7.95%)
FY2020 3.1× 2.24%
FY2019 3.0× (7.58%)
FY2018 3.3× 20.26%
FY2017 2.7× 16.04%
FY2016 2.3× 17.19%

Quarterly

Period P/S ratio Change
Jun 2026 1.9× (6.84%)
Mar 2026 2.0× 0.20%
Dec 2025 2.0× 2.54%
Sep 2025 1.9× (1.27%)
42 more quarters

Against its own ten years

Low 1.8× High 3.7×
Ten-year median 2.8×
Current reading's percentile 18

P/S ratio against peers

Company P/S ratio
MDLN Medline Inc. compare 1.0×
BAX Baxter International Inc. compare 1.1×
SOLV Solventum Corporation compare 1.9×
BDX Becton, Dickinson and Company 2.3×
ALC Alcon compare 2.9×
RMD ResMed Inc. compare 5.7×
WST West Pharmaceutical Services, Inc. compare 7.9×
ISRG Intuitive Surgical, Inc. compare 13.0×
RGEN Repligen Corporation compare 13.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on BDX